May 11, 2009
American College of Physicians
Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.
California Diabetes Program
Basic guidelines for diabetes care. This updates a previously published guideline summary.
Institute for Clinical Systems Improvement
Hypertension diagnosis and treatment. This updates a previously published guideline summary.
Venous thromboembolism prophylaxis. This updates a previously published guideline summary.
National Collaborating Centre for Mental Health
Dementia: supporting people with dementia and their carers in health and social care.
Society of Obstetricians and Gynaecologists of Canada
Conservative management of urinary incontinence.
Guideline for the management of postoperative nausea and vomiting.
Management of squamous cell cancer of the vulva.
Midurethral minimally invasive sling procedures for stress urinary incontinence.
Postpartum maternal and newborn discharge.
SOGC committee opinion on urodynamics testing.
The Endocrine Society
Prevention and treatment of pediatric obesity: an Endocrine Society clinical practice guideline.
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an Endocrine Society clinical practice guideline.
Expert Commentary
Towards a Better Value Health System — The Role of NICE in the U.K. Health Care System
By: Rubin Minhas, MB ChB
Guideline Synthesis
Updated synthesis:
Management of Overweight and Obesity in Children and Adolescents includes recommendations from AHA, MDPH, and TES.
Newly Submitted
To view a list of other guidelines in the NGC work queue, please visit our
Guidelines In Progress page.
Health Awareness Topics - May 2009
Swine Influenza
Visit the
CDC Web site for the latest information on swine influenza (flu).
Conference News
- On June 4-5, 2009, the US Cochrane Center Presents a "Stakeholder Summit on Using Quality Systematic Reviews to Inform Evidence-based Guidelines," in Baltimore, Maryland. Join leading evidence-based clinical guideline developers, and hear from experts on the latest methods and practices for systematic review and guideline development. Share successes, pitfalls, current challenges, and future opportunities for evidence-based guidelines. For more information see the US Cochrane Center Conferences and Event page.
- The 6th annual Guidelines International Network (G-I-N) conference, will be held November 1-4, 2009 in Lisbon, Portugal. Register online now. Submit abstracts until May 30, 2009. G-I-N conferences aim to bring together many colleagues from all over the world to develop collaborations with people from a wide range of organizations, through workshops, discussion, networking and informal sessions. The theme of the conference is "Evidence Translation in Different Countries." For further information and details, please visit the G-I-N Conference Web site.
Hospital-Acquired Conditions
CMS has expanded its list of hospital-acquired conditions in its final rule. According to CMS, use of evidence-based guidelines may help prevent hospital-acquired conditions. The new rule is available in the
Federal Register. For more information see NGC's listing of current guidelines on
hospital-acquired conditions.
Healthy People 2010
See NGC's
Frequently Requested Search page for a selection of pre-set searches of NGC for guidelines related to the
Healthy People 2010 focus areas, as well as other public health and patient safety topics.
Recent U.S. Food and Drug Administration (FDA) Advisories
- May 7, 2009: Testosterone gel products: FDA notified healthcare professionals that it will require two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to include a boxed warning on the products’ labels after receiving reports of adverse effects in children who were inadvertently exposed to testosterone through contact with another person being treated with these products.
- April 30, 2009: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B): Manufacturers of licensed botulinum toxin products will be required by FDA to strengthen warnings in product labeling and add a boxed warning regarding the risk of adverse events when the effects of the toxin spread beyond the site where it was injected.
NGC's Sister Resources
Find Innovations and
QualityTools classified by disease or clinical category, patient population, stage of care, setting of care, and more in AHRQ's
Health Care Innovations Exchange Web site.
Look for Quality Measures in AHRQ's
National Quality Measures Clearinghouse (NQMC).
Other Resources
To locate a previous issue of "What's New This Week," go to the
What's New Archive.
Questions or suggestions about the "What's New" feature are welcome -- please send e-mail to:
info@guideline.gov.
Submit your guidelines for inclusion in the National Guideline Clearinghouse!
Subscriptions
To sign up for our weekly NGC Update Service or to manage your subscriptions, visit the
Subscription Management page.
